Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism | Zendy

Clive Kearon | Zendy; Jeffrey S. Ginsberg | Zendy; Michael J. Kovacs | Zendy; David R. Anderson | Zendy; Philip Wells | Zendy; Jim A. Julian | Zendy; Betsy MacKin | Zendy; Jeffrey I. Weitz | Zendy; Mark Crowther | Zendy; Sean Dolan | Zendy; Alexander G.G. Turpie | Zendy; William Geerts | Zendy; Susan Solymoss | Zendy; Paul Nguyen | Zendy; Christine Demers | Zendy; Susan R. Kahn | Zendy; Jeannine Kassis | Zendy; Marc Rodger | Zendy; Julie Hambleton | Zendy; Michael Gent | Zendy

Open Access

Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

Author(s) -

Clive Kearon,

Jeffrey S. Ginsberg,

Michael J. Kovacs,

David R. Anderson,

Philip Wells,

Jim A. Julian,

Betsy MacKin,

Jeffrey I. Weitz,

Mark Crowther,

Sean Dolan,

Alexander G.G. Turpie,

William Geerts,

Susan Solymoss,

Paul Nguyen,

Christine Demers,

Susan R. Kahn,

Jeannine Kassis,

Marc Rodger,

Julie Hambleton,

Michael Gent

Publication year - 2003

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa035422

Subject(s) - medicine , warfarin , venous thromboembolism , anticoagulant therapy , anticoagulant , major bleeding , surgery , atrial fibrillation , thrombosis

Warfarin is very effective in preventing recurrent venous thromboembolism but is also associated with a substantial risk of bleeding. After three months of conventional warfarin therapy, a lower dose of anticoagulant medication may result in less bleeding and still prevent recurrent venous thromboembolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research